Article info

Download PDFPDF

Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors

Authors

  1. Correspondence to Igor Puzanov; igor.puzanov{at}roswellpark.org; Samra Turajlic; samra.turajlic{at}crick.ac.uk
View Full Text

Citation

Switzer B, Haanen J, Lorigan PC, et al
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors

Publication history

  • Accepted June 21, 2021
  • First published July 16, 2021.
Online issue publication 
July 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.